Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sinopharm Breaks Ground On Northeast Pharmaceutical Logistics Distribution Center

This article was originally published in PharmAsia News

Executive Summary

Sinopharm has broken ground on its pharmaceutical logistics distribution center in Shenyang, northeast China. The latest facility will add to its existing four large distribution centers in Beijing, Shanghai, Tianjin and Guangzhou. The company will invest RMB 630 million ($91 million) in phase one of the project, with a build-up area of 30,000 square meters. Scheduled to start operation in October 2008, it will be northeast China's largest first-class modern professional pharmaceutical distribution center. It has the capacity for storing and delivering various kinds of drugs worth up to RMB 20 billion ($2.91 billion) annually. (Click here for more - Chinese Language)

You may also be interested in...



Zimmer Biomet Buys Sternal Closure Company A&E Medical

The $250m deal adds A&E Medical’s sternal sutures, cable systems, and rigid fixation systems to Zimmer Biomet’s Dental, Spine & Craniomaxillofacial and Thoracic business.

Ovid Shifts Focus After Angelman Syndrome Drug Disappoints In Phase III

The Phase III clinical trial showed a noticeable placebo effect compared with OV101.

Becton Dickinson Expands Pre-Fillable Syringe Capacity, Anticipating Demand Surge

The company will invest $1.2bn over the next four years to expand and upgrade its manufacturing capacity for pre-fillable syringes and advanced drug delivery systems across seven manufacturing facilities.

UsernamePublicRestriction

Register

OM013195

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel